subject: Aarkstore Enterprise---global Cardiac Markers Market 2009-2013 [print this page] The market of Cardiac Markers is witnessing rapid developments, resulting in introduction and adoption of novel cardiac markers. For instance, earlier, Creatine Kinase (CK-MB) and Tropin assays were the widely utilized tests in the assessment of cardiovascular disease. However, now, markers such as Brain natriuretic peptide (BNP), myeloperoxidase (MPO), Phosphorylase isoenzyme BB (GPBB), etc., are gaining importance in the cardiovascular disease risk evaluation. Also, there has been significant advancements in new and advanced cardiac marker assays that shows superior sensitivity and accuracy, even at lower levels; thus, allowing detection of minimal cardiac injuries.
The increasing cases of cardiovascular diseases coupled with the growing aging population (as older people are more prone to cardiac-related diseases) offers a potential growth opportunity for the Cardiac Markers market. Further, with the growing popularity of point-of-care (POC), cardiac marker assay facilitating diagnostic tests to be conducted at or near the patient care site, is being widely used in hospitals. Thus, POC cardiac markers are likely to support further growth in the Cardiac Markers market.
Besides, new applications of cardiac markers are being extensively researched in different fields such as stroke, unstable coronary plaque, myocardial infarction, etc. Owing to this, there has been a significant entry of new players; intensifying the competition in the market.
This report highlights the scope of the Global Cardiac Markers market 2009-2013, along with trends, drivers, growth inhibitors and a few major vendors in the market.
